As of Feb 23
| +2.49 / +4.18%|
The 18 analysts offering 12-month price forecasts for Intercept Pharmaceuticals Inc have a median target of 107.50, with a high estimate of 253.00 and a low estimate of 50.00. The median estimate represents a +73.28% increase from the last price of 62.04.
The current consensus among 21 polled investment analysts is to Buy stock in Intercept Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.